CCM
ARKG icon

Canal Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Canal Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,352
Closed -$744K – 149
2022
Q4 		$744K Buy
26,352
+340
+1% +$10.8K 0.18% 89
2022
Q3 		$855K Buy
26,012
+3,226
+14% +$118K 0.25% 75
2022
Q2 		$718K Buy
22,786
+674
+3% +$23.6K 0.21% 78
2022
Q1 		$1.02M Sell
22,112
-4,540
-17% -$216K 0.27% 69
2021
Q4 		$1.63M Buy
26,652
+19,154
+255% +$1.32M 0.39% 62
2021
Q3 		$560K Buy
7,498
+410
+6% +$34.4K 0.16% 87
2021
Q2 		$656K Buy
7,088
+412
+6% +$35K 0.19% 84
2021
Q1 		$592K Sell
6,676
-3,537
-35% -$351K 0.2% 86
2020
Q4 		$952K Buy
10,213
+725
+8% +$57.8K 0.36% 66
2020
Q3 		$604K Buy
9,488
+1,902
+25% +$111K 0.26% 79
2020
Q2 		$396K Hold
7,586
– – 0.19% 86
2020
Q1 		$237K Buy
+7,586
New +$253K 0.13% 94

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Canal Capital Management's ARKG Position: Q1 2023 in Review

Canal Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 26,352 shares — an estimated $744K sold.

Canal Capital Management first reported a position in ARKG in Q1 2020 and held it in 12 quarters. The position peaked at $1.63M in Q4 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Canal Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Canal Capital Management sold 26,352 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $744K.
  • Canal Capital Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 12 quarters.
  • Canal Capital Management's ARK Genomic Revolution ETF position peaked at $1.63M in Q4 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Canal Capital Management's 13F filing for Q1 2023, filed 4 May 2023.